How Effective is Atomoxetine in Children and Adolescents June 27, 2022 Joshua Feder, MD and Mara Goverman With the recent approval of another non-stimulant ADHD medication (viloxazine, brand name Qelbree), this is a good time to revisit atomoxetine.Read More
General PsychiatryKarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change EverythingRead More
Child PsychiatryWhen Your Schedule Is Full: Managing Referrals in Child PsychiatryYou want to help every family that calls, but your schedule's full, and the need keeps growing. What can you do when you can't take another patient? In this episode, we will...Listen now
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024